title: Genetically engineered Mengo virus vaccination of multiple captive wildlife species.
abstract: Encephalomyocarditis virus (EMCV), has caused the deaths of many species of animals in zoological parks and research institutions. The Audubon Park Zoo, (New Orleans, Louisiana, USA) attempted vaccination of several species with a killed EMCV vaccine with mixed results. This paper reports an attempt at vaccination against EMCV using a genetically engineered, live attenuated Mengo virus (vMC0) at the Audubon Park Zoo and Miami Metro Zoo, (Miami, Florida, USA) from December 1996 to June 1997. Several species of animals were vaccinated with vMC0, which is serologically indistinguishable from the field strain of EMCV. Serum samples were taken at the time of vaccination and again 21 days later, then submitted for serum neutralization titers against EMCV. The vaccinate species included red capped mangebey (Cercocebus torquatus), colobus (Colobus guereza), angolan colobus (Colobus angolensis), ruffed lemur (Lemur variegatus ruber and Lemur variegatus variegatus), back lemur (Lemur macaco), ring-tailed lemur (Lemur catta), siamang (Hylobates syndactylus), diana guenon (Cercopithicus diana), spider monkey (Ateles geoffroyi), common marmoset (Callithrix jacchus), talapoin monkey (Cercopithecus talapoin), Brazilian tapir (Tapirus terrestris), Baird's tapir (Tapirus bairdii), Malayan tapir (Tapirus indicus), dromedary camel (Camelus dromedarius), bactrian camel (Camelus bactrianus), gerenuk (Litocranius walleri), guanaco (Lama glama guanicoe), black duiker (Cephalophus niger), Vietnamese potbellied pig (Sus scrofa), babirusa (Babyrousa babyrussa), collard peccary (Tayass tajacu), and African crested porcupine (Hystrix africaeaustralis). The vaccine response was variable, with high virus neutralizing antibody titer responses in some primate species and mixed to poor responses for other species. No ill effects were seen with vaccination.
authors.affiliation: Tulsa Zoo and Living Museum, Oklahoma 74155, USA. kbackues@ci.tulsa.ok.us
authors.forename: K A
authors.initials: KA
authors.lastname: Backues
authors.forename: M
authors.initials: M
authors.lastname: Hill
authors.forename: A C
authors.initials: AC
authors.lastname: Palmenberg
authors.forename: C
authors.initials: C
authors.lastname: Miller
authors.forename: K F
authors.initials: KF
authors.lastname: Soike
authors.forename: R
authors.initials: R
authors.lastname: Aguilar
mesh_terms: D000818:Animals; D000836:Animals, Zoo; D001188:Artiodactyla; D018188:Cardiovirus Infections / Q000517:prevention & control / Q000662:veterinary*; D005818:Genetic Engineering; D006367:HeLa Cells; D006801:Humans; D008574:Mengovirus / Q000235:genetics / Q000276:immunology*; D010527:Perissodactyla; D011323:Primates; D012377:Rodentia; D014613:Vaccines, Attenuated / Q000235:genetics; D014614:Vaccines, Synthetic / Q000235:genetics; D014765:Viral Vaccines / Q000235:genetics
chemical_list: D014613:Vaccines, Attenuated; D014614:Vaccines, Synthetic; D014765:Viral Vaccines